Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study

Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study

ABSTRACT Aims/Introduction The 2023 Delphi consensus recommended the use of new term, metabolic dysfunction‐associated steatotic liver disease (MASLD), aiming conceptual shift from the conventional non‐alcoholic fatty liver disease (NAFLD). The association between NAFLD and type 2 diabetes mellitus...

Full description

Bibliographic Details
Main Authors: Kimiko Sakai, Takuro Okamura, Ema Toyokuni, Hiroshi Okada, Akihiro Obora, Takao Kojima, Masahide Hamaguchi, Michiaki Fukui
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Journal of Diabetes Investigation
Subjects:
Liver steatosis
Non‐alcoholic fatty liver disease
Type 2 diabetes mellitus
Online Access:https://doi.org/10.1111/jdi.14315

Internet

https://doi.org/10.1111/jdi.14315

Similar Items